Muscle & Nerve · 2019 · 41 citations · 38 references
Life SciencesPathobiologyPathologyAutoimmunityAutophagyImmunopathologyAutoimmune Disease PathogenesisAutoimmune DiseasesAutophagy DysfunctionAutophagy DysregulationAutophagy In DiseaseMuscle PathologyAutoimmune MyositisAutophagy ImpairmentImmune-mediated Necrotizing MyopathyInclusion Body LesionsMitochondrial MyopathiesMuscle Fiber IntegrityNecrotizing Autoimmune MyopathySporadic Inclusion Body Myositis
ABSTRACT Introduction : The molecular mechanism of immune‐mediated necrotizing myopathy (IMNM) remains unknown. Autophagy impairment, described in autoimmune diseases, is a key process in myofiber protein degradation flux and muscle integrity and has not been studied in IMNM. Methods : Muscle biopsies from patients with IMNM ( n = 40), dermatomyositis (DM; 24), polymyositis (PM; 8), polymyositis with mitochondrial pathology (4), sporadic inclusion body myositis (8), and controls (6) were compared by immunohistochemistry. Results : The proportions of myofibers containing autophagy markers LC3b and p62 were higher in IMNM than in DM or PM and correlated with creatine kinase levels. In IMNM, compartmentalized LC3b puncta were located in regenerating and degenerating myofibers surrounded by major histocompatibility complex type II + inflammatory cells. Several IMNM myofibers accumulated ubiquitin and misfolded protein. Discussion : The detection of LC3b + or p62 + myofibers could be used in differentiating IMNM from PM. The identification of autophagy‐modifying molecules potentially could improve patients’ outcomes. Muscle Nerve , 2019
38
Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice
Masaaki Komatsu, Satoshi Waguri, Masato Koike et al. · Cell · 2007 · 2.1K citations · Full text
Jessica E. Hoogendijk, Anthony A. Amato, Bryan Lecky et al. · Neuromuscular Disorders · 2004 · 937 citations